Young Woman's DIY Detox Doesn't End Well

A 27-year-old Boston-area woman decided that if no one could fix her addiction, she'd try to hack it herself. The results were disastrous. In the New York Times, reporter Matt Richtel details how he followed "Becks" for a year as she turned to a lab-designed compound called SR-17018—bought online and labeled "NOT FOR HUMAN CONSUMPTION"—to escape a decade-long spiral through kratom, opioids, fentanyl, and more. Early doses seemed to blunt her kratom withdrawal without getting her high, feeding online buzz that this obscure chemical might be a kind of reset button for opioid dependence. To be clear, the compound's own discoverer, Dr. Laura Bohn, calls self-dosing "a terrible idea." Becks, who hoped the compound would help her detox at home, soon discovered why first-hand.

The experiment spirals into a medical crisis—and relapse into drug use—that underscores the risks of self-directed addiction treatment in an era of online chemistry and DIY pharmacology. Richtel ticks off some of the unknowns with SR in particular: "Did it expose underlying mental health issues? Could a person get briefly sober, see their opioid tolerance drop, and then use again and overdose?" Becks, now 28, survived the failed experiment and is now in a better place ("relative sobriety") after going to rehab. The piece uses her experience to illustrate a broader reality: People struggling with addiction are increasingly navigating a marketplace where cutting-edge science, internet culture, and dangerous guesswork are colliding. Read the full story.